• 1
    Stahl W,Sies H. Bioactivity and protective effects of natural carotenoids. Biochim Biophys Acta. 2005; 1740: 101-107.
  • 2
    Mayne ST. Beta-carotene, carotenoids, and disease prevention in humans. FASEB J. 1996; 10: 690-701.
  • 3
    Mayne ST,Janerich DT,Greenwald P, et al. Dietary beta carotene and lung cancer risk in U.S. nonsmokers. J Natl Cancer Inst. 1994; 86: 33-38.
  • 4
    Michaud DS,Feskanich D,Rimm EB, et al. Intake of specific carotenoids and risk of lung cancer in 2 prospective US cohorts. Am J Clin Nutr. 2000; 72: 990-997.
  • 5
    Wright ME,Mayne ST,Swanson CA,Sinha R,Alavanja MC. Dietary carotenoids, vegetables, and lung cancer risk in women: the Missouri Women's Health Study (United States). Cancer Causes Control. 2003; 14: 85-96.
  • 6
    Hennekens CH,Buring JE,Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 1996; 334: 1145-1149.
  • 7
    [No authors listed] The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med. 1994; 330: 1029-1035.
  • 8
    Omenn GS,Goodman GE,Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996; 334: 1150-1155.
  • 9
    Robles AI,Linke SP,Harris CC. The p53 network in lung carcinogenesis. Oncogene. 2002; 21: 6898-6907.
  • 10
    Wiethege T,Voss B,Muller KM. P53 accumulation and proliferating-cell nuclear antigen expression in human lung cancer. J Cancer Res Clin Oncol. 1995; 121: 371-377.
  • 11
    Jetten AM,George MA,Pettit GR,Rearick JI. Effects of bryostatins and retinoic acid on phorbol ester-and diacylglycerol-induced squamous differentiation in human tracheobronchial epithelial cells. Cancer Res. 1989; 49: 3990-3995.
  • 12
    Zhang XK,Liu Y,Lee MO. Retinoid receptors in human lung cancer and breast cancer. Mutat Res. 1996; 350: 267-277.
  • 13
    Lotan R. Retinoids in cancer chemoprevention. FASEB J. 1996; 10: 1031-1039.
  • 14
    Guengerich FP,Shimada T. Activation of procarcinogens by human cytochrome P450 enzymes. Mutat Res. 1998; 400: 201-213.
  • 15
    Liu C,Russell RM,Wang XD. Exposing ferrets to cigarette smoke and a pharmacological dose of beta-carotene supplementation enhance in vitro retinoic acid catabolism in lungs via induction of cytochrome P450 enzymes. J Nutr. 2003; 133: 173-179.
  • 16
    Liu C,Wang XD,Bronson RT,Smith DE,Krinsky NI,Russell RM. Effects of physiological versus pharmacological beta-carotene supplementation on cell proliferation and histopathological changes in the lungs of cigarette smoke-exposed ferrets. Carcinogenesis. 2000; 21: 2245-2253.
  • 17
    Liu C,Russell RM,Wang XD. Low dose beta-carotene supplementation of ferrets attenuates smoke-induced lung phosphorylation of JNK, p38 MAPK, and p53 proteins. J Nutr. 2004; 134: 2705-2710.
  • 18
    Chung J,Liu C,Smith DE,Seitz HK,Russell RM,Wang XD. Restoration of retinoic acid concentration suppresses ethanol-enhanced c-Jun expression and hepatocyte proliferation in rat liver. Carcinogenesis. 2001; 22: 1213-1219.
  • 19
    Saad RS,Liu Y,Han H,Landreneau RJ,Silverman JF. Prognostic significance of HER2/neu, p53, and vascular endothelial growth factor expression in early stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung. Mod Pathol. 2004; 17: 1235-1242.
  • 20
    Esposito V,Baldi A,De Luca A, et al. Cell cycle related proteins as prognostic parameters in radically resected non-small cell lung cancer. J Clin Pathol. 2005; 58: 734-739.
  • 21
    Chang YS,Chung JH,Shin DH, et al. Retinoic acid receptor-beta expression in stage I non-small cell lung cancer and adjacent normal appearing bronchial epithelium. Yonsei Med J. 2004; 45: 435-442.
  • 22
    Chang JT,Chang H,Chen PH,Lin SL,Lin P. Requirement of aryl hydrocarbon receptor overexpression for CYP1B1 up-regulation and cell growth in human lung adenocarcinomas. Clin Cancer Res. 2007; 13: 38-45.
  • 23
    Kim Y,Chongviriyaphan N,Liu C,Russell RM,Wang XD. Combined antioxidant (beta-carotene, alpha-tocopherol and ascorbic acid) supplementation increases the levels of lung retinoic acid and inhibits the activation of mitogen-activated protein kinase in the ferret lung cancer model. Carcinogenesis. 2006; 27: 1410-1419.
  • 24
    Zhang JY,Wang Y,Prakash C. Xenobiotic-metabolizing enzymes in human lung. Curr Drug Metab. 2006; 7: 939-948.
  • 25
    Paolini M,Antelli A,Pozzetti L, et al. Induction of cytochrome P450 enzymes and over-generation of oxygen radicals in beta-carotene supplemented rats. Carcinogenesis. 2001; 22: 1483-1495.
  • 26
    Wang XD,Liu C,Bronson RT,Smith DE,Krinsky NI,Russell M. Retinoid signaling and activator protein-1 expression in ferrets given beta-carotene supplements and exposed to tobacco smoke. J Natl Cancer Inst. 1999; 91: 60-66.
  • 27
    Gradelet S,Leclerc J,Siess MH,Astorg PO. Beta-apo-8′-carotenal, but not beta-carotene, is a strong inducer of liver cytochromes P4501A1 and 1A2 in rat. Xenobiotica. 1996; 26: 909-919.
  • 28
    Salgo MG,Cueto R,Winston GW,Pryor WA. Beta carotene and its oxidation products have different effects on microsome mediated binding of benzo[a]pyrene to DNA. Free Radic Biol Med. 1999; 26: 162-173.
  • 29
    Xu XC,Sozzi G,Lee JS, et al. Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: implications for lung cancer development. J Natl Cancer Inst. 1997; 89: 624-629.
  • 30
    Houle B,Rochette-Egly C,Bradley WE. Tumor-suppressive effect of the retinoic acid receptor beta in human epidermoid lung cancer cells. Proc Natl Acad Sci USA. 1993; 90: 985-989.
  • 31
    Mernitz H,Smith DE,Zhu AX,Wang XD. 9-cis-Retinoic acid inhibition of lung carcinogenesis in the A/J mouse model is accompanied by increased expression of RAR-beta but no change in cyclooxygenase-2. Cancer Lett. 2006; 244: 101-108.
  • 32
    Kurie JM,Lotan R,Lee JJ, et al. Treatment of former smokers with 9-cis-retinoic acid reverses loss of retinoic acid receptor-beta expression in the bronchial epithelium: results from a randomized placebo-controlled trial. J Natl Cancer Inst. 2003; 95: 206-214.
  • 33
    Khuri FR,Lotan R,Kemp BL, et al. Retinoic acid receptor-beta as a prognostic indicator in stage I non-small-cell lung cancer. J Clin Oncol. 2000; 18: 2798-2804.